# Vertex Pharmaceuticals
> Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero.
## Record
| Field | Value |
| --- | --- |
| Representation | alpha-profile-markdown-v4 |
| Protocol | Alpha Governance Facts Protocol 0.1 |
| Schema | alpha.governance.entity.public.v1 |
| Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce |
| Governance record representation | alpha-governance-record-v2 |
| Canonical entity | alpha:company:67a28a17-ff7a-4e42-a246-5086ab42eca9 |
| Entity type | Company |
| Canonical URL | https://registry.alpha.ac/companies/vertex-pharmaceuticals-inc-ma |
| Publication | PUBLISHED |
| Verification | source_reported |
| Verification schema | alpha-verification-states-v1 |
| Ownership | unclaimed |
| Published claims | 52 |
| Claims under review | 1 |
| Evidence records | 26 |
| Conflicts | 0 |
| Conflicts in internal review | 0 |
| Observed | 2026-10-16T13:51:24.289996+00:00 |
| Last reviewed | 2026-10-16T13:51:24.289996+00:00 |
## Identity
- Legal name: VERTEX PHARMACEUTICALS INC / MA
- Display name: Vertex Pharmaceuticals
## Alpha Governance Record
| Field | Value |
| --- | --- |
| Governance Record schema | alpha-governance-record-v2 |
| Ontology | alpha-governance-ontology-v1 |
| Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce |
| As of | 2026-10-16T14:35:28.201569+00:00 |
| Completeness | 0.455 |
| Record Quality | 0.804 |
| Directors | 11 |
| Committees | 9 |
| Governance events | 23 |
| Entity class | public_company |
## Section coverage
| Section | State |
| --- | --- |
| identity | PUBLISHED |
| corporate_structure | NOT_REVIEWED |
| board | PUBLISHED |
| committees | PUBLISHED |
| leadership | PUBLISHED |
| ownership | NOT_REVIEWED |
| financials | NOT_REVIEWED |
| capital_structure | PUBLISHED |
| compensation | NOT_REVIEWED |
| governance | NOT_REVIEWED |
| shareholder_governance | NOT_REVIEWED |
| audit | NOT_REVIEWED |
| legal | NOT_REVIEWED |
| risk | NOT_REVIEWED |
| cyber | NOT_REVIEWED |
| ai_governance | NOT_REVIEWED |
| agent_governance | RESTRICTED |
| markets_external | PUBLISHED |
| events | PUBLISHED |
| relationships | PUBLISHED |
| assessments | PUBLISHED |
| evidence | PUBLISHED |
## Board
- Alan Garber: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2017-01-01. Committees: CGNC (member); CGNC; Nominating and Governance (member); Nominating and Governance (member). claim_id=alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:10
- Bruce Sachs: Lead Independent Director. Status: current. Independent: NOT_PUBLISHED. Since: 1998-01-01. claim_id=alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:11
- Diana McKenzie: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2020-01-01. Committees: Audit (member); Audit; MDCC; Compensation (member); Compensation (member); MDCC (member). claim_id=alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:12
- Jeffrey M. Leiden: Chair. Status: current. Independent: NOT_PUBLISHED. Since: 2009-01-01. claim_id=alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:9
- Jennifer Schneider: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2024-01-01. Committees: Compensation (member); MDCC (member); MDCC; Compensation (member). claim_id=alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:13
- Lloyd Carney: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2019-01-01. Committees: Audit (member); Audit; CGNC; Nominating and Governance (member); CGNC (member); Nominating and Governance (member). claim_id=alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:14
- Michel Lagarde: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2023-01-01. Committees: Audit (member). claim_id=alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:15
- Nancy Thornberry: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2023-01-01. claim_id=alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:16
- Reshma Kewalramani: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2020-01-01. claim_id=alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:17
- Sangeeta Bhatia: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2015-01-01. Committees: CGNC (member); CGNC; Nominating and Governance (member); Nominating and Governance (member). claim_id=alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:18
- Suketu Upadhyay: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2022-01-01. Committees: Audit (member); Audit; MDCC; Compensation (member); Compensation (member); MDCC (member). claim_id=alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:19
## Committees
- Audit (audit). Chair: NOT_PUBLISHED. Members: Diana McKenzie (member, current); Lloyd Carney (member, current); Michel Lagarde (member, current); Suketu Upadhyay (member, current). committee_id=alpha:committee:vertex-pharmaceuticals-inc-ma:audit
- Audit; CGNC; Nominating and Governance (audit). Chair: NOT_PUBLISHED. Members: Lloyd Carney (member, current). committee_id=alpha:committee:vertex-pharmaceuticals-inc-ma:audit-cgnc-nominating-and-governance
- Audit; MDCC; Compensation (audit). Chair: NOT_PUBLISHED. Members: Diana McKenzie (member, current); Suketu Upadhyay (member, current). committee_id=alpha:committee:vertex-pharmaceuticals-inc-ma:audit-mdcc-compensation
- CGNC (other). Chair: NOT_PUBLISHED. Members: Alan Garber (member, current); Lloyd Carney (member, current); Sangeeta Bhatia (member, current). committee_id=alpha:committee:vertex-pharmaceuticals-inc-ma:cgnc
- CGNC; Nominating and Governance (nominating_governance). Chair: NOT_PUBLISHED. Members: Alan Garber (member, current); Sangeeta Bhatia (member, current). committee_id=alpha:committee:vertex-pharmaceuticals-inc-ma:cgnc-nominating-and-governance
- Compensation (compensation). Chair: NOT_PUBLISHED. Members: Diana McKenzie (member, current); Jennifer Schneider (member, current); Suketu Upadhyay (member, current). committee_id=alpha:committee:vertex-pharmaceuticals-inc-ma:compensation
- MDCC (other). Chair: NOT_PUBLISHED. Members: Diana McKenzie (member, current); Jennifer Schneider (member, current); Suketu Upadhyay (member, current). committee_id=alpha:committee:vertex-pharmaceuticals-inc-ma:mdcc
- MDCC; Compensation (compensation). Chair: NOT_PUBLISHED. Members: Jennifer Schneider (member, current). committee_id=alpha:committee:vertex-pharmaceuticals-inc-ma:mdcc-compensation
- Nominating and Governance (nominating_governance). Chair: NOT_PUBLISHED. Members: Alan Garber (member, current); Lloyd Carney (member, current); Sangeeta Bhatia (member, current). committee_id=alpha:committee:vertex-pharmaceuticals-inc-ma:nominating-and-governance
## Executive leadership
- Amit K. Sachdev, J.D.: Executive Vice President, Chief Patient and External Affairs Officer. Status: unknown. claim_id=alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:20
- Charles F. Wagner, Jr.: Executive Vice President, Chief Operating and Financial Officer. Status: unknown. claim_id=alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:21
- Craig B. Thompson, M.D.: Executive Vice President, Global Medicines Development and Medical Affairs, and Chief Medical Officer. Status: unknown. claim_id=alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:22
- Duncan J. McKechnie: Executive Vice President, Chief Commercial Officer. Status: unknown. claim_id=alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:23
- E. Morrow Morrey Atkinson, III, Ph.D.: Executive Vice President, Chief Technical Operations Officer, Head of Biopharmaceutical Science and Manufacturing Operations. Status: unknown. claim_id=alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:24
- Jonathan Biller, J.D.: Executive Vice President, Chief Legal Officer [GC]. Status: unknown. claim_id=alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:25
- Kristen C. Ambrose, CPA: Senior Vice President, Chief Accounting Officer [CAO]. Status: unknown. claim_id=alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:26
- Mark Bunnage, D.Phil: Executive Vice President, Chief Scientific Officer. Status: unknown. claim_id=alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:27
- Ourania Nia Tatsis, Ph.D.: Executive Vice President, Chief Regulatory and Quality Officer. Status: unknown. claim_id=alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:28
- Reshma Kewalramani, M.D.: Chief Executive Officer and President [CEO]. Status: unknown. claim_id=alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:29
## Governance events
- DIRECTOR_APPOINTED: Jennifer Schneider seat on Vertex Pharmaceuticals, effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-16T13:51:24.289996+00:00. event_id=alpha:event:transition:15u6me2dbz7ig
- COMMITTEE_CREATED: MDCC; Compensation committee of Vertex Pharmaceuticals, effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-16T13:51:24.289996+00:00. event_id=alpha:event:transition:1vmnpuaedw0m8
- COMMITTEE_MEMBER_ADDED: Jennifer Schneider member of MDCC; Compensation, effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-16T13:51:24.289996+00:00. event_id=alpha:event:transition:1p0t2dk6rkfa0
- DIRECTOR_APPOINTED: Michel Lagarde seat on Vertex Pharmaceuticals, effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-16T13:51:24.289996+00:00. event_id=alpha:event:transition:19o2wj331gke7
- DIRECTOR_APPOINTED: Nancy Thornberry seat on Vertex Pharmaceuticals, effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-16T13:51:24.289996+00:00. event_id=alpha:event:transition:gyd9bvy3rn9t
- DIRECTOR_APPOINTED: Suketu Upadhyay seat on Vertex Pharmaceuticals, effective 2022-01-01. Effective: 2022-01-01. Detected: 2026-10-16T13:51:24.289996+00:00. event_id=alpha:event:transition:1ngweg11ggmvjn
- COMMITTEE_MEMBER_ADDED: Suketu Upadhyay member of Audit; MDCC; Compensation, effective 2022-01-01. Effective: 2022-01-01. Detected: 2026-10-16T13:51:24.289996+00:00. event_id=alpha:event:transition:1de145fgl55qr
- DIRECTOR_APPOINTED: Diana McKenzie seat on Vertex Pharmaceuticals, effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-16T13:51:24.289996+00:00. event_id=alpha:event:transition:18piqbt1l3caw9
- DIRECTOR_APPOINTED: Reshma Kewalramani seat on Vertex Pharmaceuticals, effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-16T13:51:24.289996+00:00. event_id=alpha:event:transition:1p2ojm518sz507
- COMMITTEE_CREATED: Audit; MDCC; Compensation committee of Vertex Pharmaceuticals, effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-16T13:51:24.289996+00:00. event_id=alpha:event:transition:g7epkx1y0ru4f
- COMMITTEE_MEMBER_ADDED: Diana McKenzie member of Audit; MDCC; Compensation, effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-16T13:51:24.289996+00:00. event_id=alpha:event:transition:celd3z15m11up
- DIRECTOR_APPOINTED: Lloyd Carney seat on Vertex Pharmaceuticals, effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-16T13:51:24.289996+00:00. event_id=alpha:event:transition:akg3m910gpbjz
- COMMITTEE_CREATED: Audit; CGNC; Nominating and Governance committee of Vertex Pharmaceuticals, effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-16T13:51:24.289996+00:00. event_id=alpha:event:transition:j2mrhb20z2iz
- COMMITTEE_MEMBER_ADDED: Lloyd Carney member of Audit; CGNC; Nominating and Governance, effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-16T13:51:24.289996+00:00. event_id=alpha:event:transition:eog2i61hlysqs
- DIRECTOR_APPOINTED: Alan Garber seat on Vertex Pharmaceuticals, effective 2017-01-01. Effective: 2017-01-01. Detected: 2026-10-16T13:51:24.289996+00:00. event_id=alpha:event:transition:7nes6w1cycgd6
- COMMITTEE_CREATED: CGNC; Nominating and Governance committee of Vertex Pharmaceuticals, effective 2017-01-01. Effective: 2017-01-01. Detected: 2026-10-16T13:51:24.289996+00:00. event_id=alpha:event:transition:50ai1d1wa7xqf
- COMMITTEE_MEMBER_ADDED: Alan Garber member of CGNC; Nominating and Governance, effective 2017-01-01. Effective: 2017-01-01. Detected: 2026-10-16T13:51:24.289996+00:00. event_id=alpha:event:transition:12cutrnv6kotd
- DIRECTOR_APPOINTED: Sangeeta Bhatia seat on Vertex Pharmaceuticals, effective 2015-01-01. Effective: 2015-01-01. Detected: 2026-10-16T13:51:24.289996+00:00. event_id=alpha:event:transition:ksrc3z11b5s7l
- COMMITTEE_MEMBER_ADDED: Sangeeta Bhatia member of CGNC; Nominating and Governance, effective 2015-01-01. Effective: 2015-01-01. Detected: 2026-10-16T13:51:24.289996+00:00. event_id=alpha:event:transition:1ah28b4m13zo2
- DIRECTOR_APPOINTED: Jeffrey M. Leiden seat on Vertex Pharmaceuticals, effective 2009-01-01. Effective: 2009-01-01. Detected: 2026-10-16T13:51:24.289996+00:00. event_id=alpha:event:transition:pqcndg1wtiigy
- BOARD_CHAIR_CHANGED: Jeffrey M. Leiden chairs board Vertex Pharmaceuticals, effective 2009-01-01. Effective: 2009-01-01. Detected: 2026-10-16T13:51:24.289996+00:00. event_id=alpha:event:transition:1mq6iwi7oulnq
- DIRECTOR_APPOINTED: Bruce Sachs seat on Vertex Pharmaceuticals, effective 1998-01-01. Effective: 1998-01-01. Detected: 2026-10-16T13:51:24.289996+00:00. event_id=alpha:event:transition:1doeq6bvs8w8x
- LEAD_DIRECTOR_CHANGED: Bruce Sachs lead independent director of Vertex Pharmaceuticals, effective 1998-01-01. Effective: 1998-01-01. Detected: 2026-10-16T13:51:24.289996+00:00. event_id=alpha:event:transition:z838t3hrrg69
## Scoped resources
- `alpha://company/vertex-pharmaceuticals-inc-ma` (contract): https://registry.alpha.ac/api/public/companies/vertex-pharmaceuticals-inc-ma?format=record
- `alpha://company/vertex-pharmaceuticals-inc-ma/identity` (contract): https://registry.alpha.ac/api/public/companies/vertex-pharmaceuticals-inc-ma?format=record§ion=identity
- `alpha://company/vertex-pharmaceuticals-inc-ma/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/vertex-pharmaceuticals-inc-ma?format=record§ion=corporate-structure
- `alpha://company/vertex-pharmaceuticals-inc-ma/board` (contract): https://registry.alpha.ac/api/public/companies/vertex-pharmaceuticals-inc-ma?format=record§ion=board
- `alpha://company/vertex-pharmaceuticals-inc-ma/committees` (contract): https://registry.alpha.ac/api/public/companies/vertex-pharmaceuticals-inc-ma?format=record§ion=committees
- `alpha://company/vertex-pharmaceuticals-inc-ma/leadership` (contract): https://registry.alpha.ac/api/public/companies/vertex-pharmaceuticals-inc-ma?format=record§ion=leadership
- `alpha://company/vertex-pharmaceuticals-inc-ma/ownership` (contract): https://registry.alpha.ac/api/public/companies/vertex-pharmaceuticals-inc-ma?format=record§ion=ownership
- `alpha://company/vertex-pharmaceuticals-inc-ma/financials` (contract): https://registry.alpha.ac/api/public/companies/vertex-pharmaceuticals-inc-ma?format=record§ion=financials
- `alpha://company/vertex-pharmaceuticals-inc-ma/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/vertex-pharmaceuticals-inc-ma?format=record§ion=capital-structure
- `alpha://company/vertex-pharmaceuticals-inc-ma/compensation` (contract): https://registry.alpha.ac/api/public/companies/vertex-pharmaceuticals-inc-ma?format=record§ion=compensation
- `alpha://company/vertex-pharmaceuticals-inc-ma/governance` (contract): https://registry.alpha.ac/api/public/companies/vertex-pharmaceuticals-inc-ma?format=record§ion=governance
- `alpha://company/vertex-pharmaceuticals-inc-ma/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/vertex-pharmaceuticals-inc-ma?format=record§ion=shareholder-governance
- `alpha://company/vertex-pharmaceuticals-inc-ma/audit` (contract): https://registry.alpha.ac/api/public/companies/vertex-pharmaceuticals-inc-ma?format=record§ion=audit
- `alpha://company/vertex-pharmaceuticals-inc-ma/legal` (contract): https://registry.alpha.ac/api/public/companies/vertex-pharmaceuticals-inc-ma?format=record§ion=legal
- `alpha://company/vertex-pharmaceuticals-inc-ma/risk` (contract): https://registry.alpha.ac/api/public/companies/vertex-pharmaceuticals-inc-ma?format=record§ion=risk
- `alpha://company/vertex-pharmaceuticals-inc-ma/cyber` (contract): https://registry.alpha.ac/api/public/companies/vertex-pharmaceuticals-inc-ma?format=record§ion=cyber
- `alpha://company/vertex-pharmaceuticals-inc-ma/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/vertex-pharmaceuticals-inc-ma?format=record§ion=ai-governance
- `alpha://company/vertex-pharmaceuticals-inc-ma/agents` (contract): https://registry.alpha.ac/api/public/companies/vertex-pharmaceuticals-inc-ma?format=record§ion=agents
- `alpha://company/vertex-pharmaceuticals-inc-ma/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/vertex-pharmaceuticals-inc-ma?format=record§ion=ecosystem
- `alpha://company/vertex-pharmaceuticals-inc-ma/events` (contract): https://registry.alpha.ac/api/public/companies/vertex-pharmaceuticals-inc-ma?format=record§ion=events
- `alpha://company/vertex-pharmaceuticals-inc-ma/relationships` (contract): https://registry.alpha.ac/api/public/companies/vertex-pharmaceuticals-inc-ma?format=record§ion=relationships
- `alpha://company/vertex-pharmaceuticals-inc-ma/assessments` (contract): https://registry.alpha.ac/api/public/companies/vertex-pharmaceuticals-inc-ma?format=record§ion=assessments
- `alpha://company/vertex-pharmaceuticals-inc-ma/evidence` (contract): https://registry.alpha.ac/api/public/companies/vertex-pharmaceuticals-inc-ma?format=record§ion=evidence
## Role modules
- NOT_ASSERTED
## Attention
- NO_RECORDS_FOUND
## Committee data
- Claim alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:committee_appointment:31: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:diana-mckenzie","name":"Diana McKenzie"},"source_id":"board_seats"}`
- Claim alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:committee_appointment:32: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:lloyd-carney","name":"Lloyd Carney"},"source_id":"board_seats"}`
- Claim alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:committee_appointment:33: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:michel-lagarde","name":"Michel Lagarde"},"source_id":"board_seats"}`
- Claim alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:committee_appointment:34: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:suketu-upadhyay","name":"Suketu Upadhyay"},"source_id":"board_seats"}`
- Claim alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:committee_appointment:36: `{"kind":"committee_appointment","original_name":"CGNC","category":"other","role":"member","person":{"alpha_id":"alpha:person:alan-garber","name":"Alan Garber"},"source_id":"board_seats"}`
- Claim alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:committee_appointment:37: `{"kind":"committee_appointment","original_name":"CGNC","category":"other","role":"member","person":{"alpha_id":"alpha:person:lloyd-carney","name":"Lloyd Carney"},"source_id":"board_seats"}`
- Claim alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:committee_appointment:38: `{"kind":"committee_appointment","original_name":"CGNC","category":"other","role":"member","person":{"alpha_id":"alpha:person:sangeeta-bhatia","name":"Sangeeta Bhatia"},"source_id":"board_seats"}`
- Claim alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:committee_appointment:40: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:diana-mckenzie","name":"Diana McKenzie"},"source_id":"board_seats"}`
- Claim alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:committee_appointment:41: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:jennifer-schneider","name":"Jennifer Schneider"},"source_id":"board_seats"}`
- Claim alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:committee_appointment:42: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:suketu-upadhyay","name":"Suketu Upadhyay"},"source_id":"board_seats"}`
- Claim alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:committee_appointment:44: `{"kind":"committee_appointment","original_name":"MDCC","category":"other","role":"member","person":{"alpha_id":"alpha:person:diana-mckenzie","name":"Diana McKenzie"},"source_id":"board_seats"}`
- Claim alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:committee_appointment:45: `{"kind":"committee_appointment","original_name":"MDCC","category":"other","role":"member","person":{"alpha_id":"alpha:person:jennifer-schneider","name":"Jennifer Schneider"},"source_id":"board_seats"}`
- Claim alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:committee_appointment:46: `{"kind":"committee_appointment","original_name":"MDCC","category":"other","role":"member","person":{"alpha_id":"alpha:person:suketu-upadhyay","name":"Suketu Upadhyay"},"source_id":"board_seats"}`
- Claim alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:committee_appointment:48: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:alan-garber","name":"Alan Garber"},"source_id":"board_seats"}`
- Claim alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:committee_appointment:49: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:lloyd-carney","name":"Lloyd Carney"},"source_id":"board_seats"}`
- Claim alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:committee_appointment:50: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:sangeeta-bhatia","name":"Sangeeta Bhatia"},"source_id":"board_seats"}`
## Leadership
- Jeffrey M. Leiden: Chair. Claim: alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:9. Valid from: 2009-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:4204b33890421295f8e7a46549171c478894d031cbbeaf34c4d37a139f430827.
- Alan Garber: Director, CGNC; Nominating and Governance. Claim: alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:10. Valid from: 2017-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b9e93410980e0de555ceb4e5a4d7ad206b129a10d48051765eabd6aac39769cc.
- Bruce Sachs: Lead Independent Director. Claim: alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:11. Valid from: 1998-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:56bd4087aac2efb2a4f1ba7b4ec47c52e892e0a1f2b3f43408a98943c5b78b94.
- Diana McKenzie: Director, Audit; MDCC; Compensation. Claim: alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:12. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:3a71ee491d4edd7ad4c444364a54a6cd98e460c73c0e4a530f213dc158d42163.
- Jennifer Schneider: Director, MDCC; Compensation. Claim: alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:13. Valid from: 2024-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f71d7ad63d317a89a9a896279a66a7b5677513bdc42b3aedecfff0ae33710b7f.
- Lloyd Carney: Director, Audit; CGNC; Nominating and Governance. Claim: alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:14. Valid from: 2019-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:c0e47d7c4b33b030ce488922138a8c66f509c7255719adf92e5fa78fc8a4315a.
- Michel Lagarde: Director, Audit. Claim: alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:15. Valid from: 2023-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:4488043de931797e682a0536afc312cae15082e3f75b3d0b6fe366f5bb05bca4.
- Nancy Thornberry: Director. Claim: alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:16. Valid from: 2023-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:3d9bdbb6429f64e8b2097690ef5c293918cb8bd125d855b9b9f14945d6186a6a.
- Reshma Kewalramani: Director. Claim: alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:17. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:40fbba593a76c37fecbd172eaa34cbf956f7086dc717081d95a2a6812f5f78ec.
- Sangeeta Bhatia: Director, CGNC; Nominating and Governance. Claim: alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:18. Valid from: 2015-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:00cf7db9df23d437fa08d5fa748d02f566c1f00005ca782a52b7a6b0fd9dfa87.
- Suketu Upadhyay: Director, Audit; MDCC; Compensation. Claim: alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:19. Valid from: 2022-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:65aa0f473458ddc2d4211d222c40e747b4e05982619bf8cfdbf0acff95ada785.
- Amit K. Sachdev, J.D.: Executive Vice President, Chief Patient and External Affairs Officer. Claim: alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:643565076b28be530e27bc7c6bb3b8e5c4f9d2ef18b6ed3c3477341241fc6f2d.
- Charles F. Wagner, Jr.: Executive Vice President, Chief Operating and Financial Officer. Claim: alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:10073b8c8eebe93a66db157b64687d2d3997bc19eb9044ee3696d363709c8ca8.
- Craig B. Thompson, M.D.: Executive Vice President, Global Medicines Development and Medical Affairs, and Chief Medical Officer. Claim: alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:bcba2bd490d216b470f7f5bfee08ab970104433bf97d57f0ffbc8c0646e2f879.
- Duncan J. McKechnie: Executive Vice President, Chief Commercial Officer. Claim: alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:23. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:ecb260e2fc826c6ce0d9dc519493846b3dad9f6e6755e4e91fe7588cfad341c0.
- E. Morrow Morrey Atkinson, III, Ph.D.: Executive Vice President, Chief Technical Operations Officer, Head of Biopharmaceutical Science and Manufacturing Operations. Claim: alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:24. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:d6d906836dc60a9cb04c04a972bfe36d39683fb549b84171d05c66770d06294e.
- Jonathan Biller, J.D.: Executive Vice President, Chief Legal Officer. Claim: alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:25. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:11c9716331af59ab69a0aebe420f77e14312aef120cdd656894afe2d18781f2b.
- Kristen C. Ambrose, CPA: Senior Vice President, Chief Accounting Officer. Claim: alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:26. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:928c35a8eb10908bfafa795855984082d0cf83fa1beaab5098328b05eb4f4dbe.
- Mark Bunnage, D.Phil: Executive Vice President, Chief Scientific Officer. Claim: alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:27. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:a12b804ccfa191b0a98a7bf01680ad0b850214b84d0467db3d7f4efedc2d6e5b.
- Ourania Nia Tatsis, Ph.D.: Executive Vice President, Chief Regulatory and Quality Officer. Claim: alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:28. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:15a914491ac61cea12830ac4dae1f930b6ac324a037cb07cbd6c3f1bcb573247.
- Reshma Kewalramani, M.D.: Chief Executive Officer and President. Claim: alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:leadership_role:29. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:bd8e625c43229cd60017e6c676a3355f568a031ad70b6019bbdfc8ac786e4c03.
## Roles
- PUBLISHED
## Governance
- NOT_ASSERTED
## Board committees
- Audit: Chair not stated; Members Diana McKenzie; Lloyd Carney; Michel Lagarde; Suketu Upadhyay. Claim: alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:committee_record:30. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a272f1cf1c94c10710da2da022a424e6b3312f2261f8ff8157329e967abc5f34.
- CGNC: Chair not stated; Members Alan Garber; Lloyd Carney; Sangeeta Bhatia. Claim: alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:committee_record:35. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a272f1cf1c94c10710da2da022a424e6b3312f2261f8ff8157329e967abc5f34.
- Compensation: Chair not stated; Members Diana McKenzie; Jennifer Schneider; Suketu Upadhyay. Claim: alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:committee_record:39. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a272f1cf1c94c10710da2da022a424e6b3312f2261f8ff8157329e967abc5f34.
- MDCC: Chair not stated; Members Diana McKenzie; Jennifer Schneider; Suketu Upadhyay. Claim: alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:committee_record:43. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a272f1cf1c94c10710da2da022a424e6b3312f2261f8ff8157329e967abc5f34.
- Nominating and Governance: Chair not stated; Members Alan Garber; Lloyd Carney; Sangeeta Bhatia. Claim: alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:committee_record:47. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a272f1cf1c94c10710da2da022a424e6b3312f2261f8ff8157329e967abc5f34.
## Financials
- NOT_ASSERTED
## Workforce
- NOT_ASSERTED
## Market and index context
- S&P 500 (SPX). Claim: alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:index_membership:51. Valid from: 2013-09-23. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:827a22a1567eda11fa866650563f33918ee2975144378fa7fd6f46399da5427a.
- Nasdaq-100 (NDX). Claim: alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:index_membership:52. Valid from: 2026-09-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:24e3e0a1948ea10a66303a2e7032cc9bbc5c4edf5c6d4eb77b262a15ea2009a5.
## Legal Name
- VERTEX PHARMACEUTICALS INC / MA. Claim: alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:3689ca642bfc033d173b2bc49bafdfee36e7db450c6b987dfdf226863ed0bae7.
## Entity Status
- Public listing published. Claim: alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:3689ca642bfc033d173b2bc49bafdfee36e7db450c6b987dfdf226863ed0bae7.
## Official Website
- https://www.vrtx.com. Claim: alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:official_website:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:9015985fad92d88e74db5c67c27c419035e65a05002428d7db43c41165fb4d6f.
## Published Fact
- US. Claim: alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:published_fact:5. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:3689ca642bfc033d173b2bc49bafdfee36e7db450c6b987dfdf226863ed0bae7.
- MA. Claim: alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:published_fact:6. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:3689ca642bfc033d173b2bc49bafdfee36e7db450c6b987dfdf226863ed0bae7.
- Healthcare. Claim: alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:published_fact:7. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:3689ca642bfc033d173b2bc49bafdfee36e7db450c6b987dfdf226863ed0bae7.
- https://www.vrtx.com. Claim: alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:published_fact:8. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:9015985fad92d88e74db5c67c27c419035e65a05002428d7db43c41165fb4d6f.
## Committee Appointment
- Diana McKenzie: member, Audit. Claim: alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:committee_appointment:31. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a272f1cf1c94c10710da2da022a424e6b3312f2261f8ff8157329e967abc5f34.
- Lloyd Carney: member, Audit. Claim: alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:committee_appointment:32. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a272f1cf1c94c10710da2da022a424e6b3312f2261f8ff8157329e967abc5f34.
- Michel Lagarde: member, Audit. Claim: alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:committee_appointment:33. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a272f1cf1c94c10710da2da022a424e6b3312f2261f8ff8157329e967abc5f34.
- Suketu Upadhyay: member, Audit. Claim: alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:committee_appointment:34. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a272f1cf1c94c10710da2da022a424e6b3312f2261f8ff8157329e967abc5f34.
- Alan Garber: member, CGNC. Claim: alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:committee_appointment:36. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a272f1cf1c94c10710da2da022a424e6b3312f2261f8ff8157329e967abc5f34.
- Lloyd Carney: member, CGNC. Claim: alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:committee_appointment:37. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a272f1cf1c94c10710da2da022a424e6b3312f2261f8ff8157329e967abc5f34.
- Sangeeta Bhatia: member, CGNC. Claim: alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:committee_appointment:38. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a272f1cf1c94c10710da2da022a424e6b3312f2261f8ff8157329e967abc5f34.
- Diana McKenzie: member, Compensation. Claim: alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:committee_appointment:40. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a272f1cf1c94c10710da2da022a424e6b3312f2261f8ff8157329e967abc5f34.
- Jennifer Schneider: member, Compensation. Claim: alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:committee_appointment:41. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a272f1cf1c94c10710da2da022a424e6b3312f2261f8ff8157329e967abc5f34.
- Suketu Upadhyay: member, Compensation. Claim: alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:committee_appointment:42. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a272f1cf1c94c10710da2da022a424e6b3312f2261f8ff8157329e967abc5f34.
- Diana McKenzie: member, MDCC. Claim: alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:committee_appointment:44. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a272f1cf1c94c10710da2da022a424e6b3312f2261f8ff8157329e967abc5f34.
- Jennifer Schneider: member, MDCC. Claim: alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:committee_appointment:45. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a272f1cf1c94c10710da2da022a424e6b3312f2261f8ff8157329e967abc5f34.
- Suketu Upadhyay: member, MDCC. Claim: alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:committee_appointment:46. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a272f1cf1c94c10710da2da022a424e6b3312f2261f8ff8157329e967abc5f34.
- Alan Garber: member, Nominating and Governance. Claim: alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:committee_appointment:48. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a272f1cf1c94c10710da2da022a424e6b3312f2261f8ff8157329e967abc5f34.
- Lloyd Carney: member, Nominating and Governance. Claim: alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:committee_appointment:49. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a272f1cf1c94c10710da2da022a424e6b3312f2261f8ff8157329e967abc5f34.
- Sangeeta Bhatia: member, Nominating and Governance. Claim: alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:committee_appointment:50. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a272f1cf1c94c10710da2da022a424e6b3312f2261f8ff8157329e967abc5f34.
## Security Listing
- VRTX (NASDAQ). Claim: alpha:claim:company:67a28a17-ff7a-4e42-a246-5086ab42eca9:security_listing:53. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:3689ca642bfc033d173b2bc49bafdfee36e7db450c6b987dfdf226863ed0bae7.
## Coverage states
| Field | Value |
| --- | --- |
| Identity | PUBLISHED |
| Business | PUBLISHED |
| Leadership | PUBLISHED |
| Board and committees | PUBLISHED |
| Governance | NOT_ASSERTED |
| Financials | NOT_ASSERTED |
| Workforce | NOT_ASSERTED |
| Ownership | NOT_ASSERTED |
| Ratings | NOT_PUBLISHED |
| Market and index context | PUBLISHED |
## Public sources
- alpha:projection-evidence:3689ca642bfc033d173b2bc49bafdfee36e7db450c6b987dfdf226863ed0bae7: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/vertex-pharmaceuticals-inc-ma).
- alpha:projection-evidence:9015985fad92d88e74db5c67c27c419035e65a05002428d7db43c41165fb4d6f: [VERTEX PHARMACEUTICALS INC / MA Form 10-K (filed 2026-02-13)](https://www.sec.gov/Archives/edgar/data/875320/000087532026000056/vrtx-20251231.htm).
- alpha:projection-evidence:document:4204b33890421295f8e7a46549171c478894d031cbbeaf34c4d37a139f430827: [Vertex Pharmaceuticals Incorporated director board source](https://www.sec.gov/Archives/edgar/data/0000875320/000087532025000160/vrtx-20250403.htm).
- alpha:projection-evidence:document:b9e93410980e0de555ceb4e5a4d7ad206b129a10d48051765eabd6aac39769cc: [Vertex Pharmaceuticals Incorporated director board source](https://www.sec.gov/Archives/edgar/data/0000875320/000087532025000160/vrtx-20250403.htm).
- alpha:projection-evidence:document:56bd4087aac2efb2a4f1ba7b4ec47c52e892e0a1f2b3f43408a98943c5b78b94: [Vertex Pharmaceuticals Incorporated director board source](https://www.sec.gov/Archives/edgar/data/0000875320/000087532025000160/vrtx-20250403.htm).
- alpha:projection-evidence:document:3a71ee491d4edd7ad4c444364a54a6cd98e460c73c0e4a530f213dc158d42163: [Vertex Pharmaceuticals Incorporated director board source](https://www.sec.gov/Archives/edgar/data/0000875320/000087532025000160/vrtx-20250403.htm).
- alpha:projection-evidence:document:f71d7ad63d317a89a9a896279a66a7b5677513bdc42b3aedecfff0ae33710b7f: [Vertex Pharmaceuticals Incorporated director board source](https://www.sec.gov/Archives/edgar/data/0000875320/000087532025000160/vrtx-20250403.htm).
- alpha:projection-evidence:document:c0e47d7c4b33b030ce488922138a8c66f509c7255719adf92e5fa78fc8a4315a: [Vertex Pharmaceuticals Incorporated director board source](https://www.sec.gov/Archives/edgar/data/0000875320/000087532025000160/vrtx-20250403.htm).
- alpha:projection-evidence:document:4488043de931797e682a0536afc312cae15082e3f75b3d0b6fe366f5bb05bca4: [Vertex Pharmaceuticals Incorporated director board source](https://www.sec.gov/Archives/edgar/data/0000875320/000087532025000160/vrtx-20250403.htm).
- alpha:projection-evidence:document:3d9bdbb6429f64e8b2097690ef5c293918cb8bd125d855b9b9f14945d6186a6a: [Vertex Pharmaceuticals Incorporated director board source](https://www.sec.gov/Archives/edgar/data/0000875320/000087532025000160/vrtx-20250403.htm).
- alpha:projection-evidence:document:40fbba593a76c37fecbd172eaa34cbf956f7086dc717081d95a2a6812f5f78ec: [Vertex Pharmaceuticals Incorporated director board source](https://www.sec.gov/Archives/edgar/data/0000875320/000087532025000160/vrtx-20250403.htm).
- alpha:projection-evidence:document:00cf7db9df23d437fa08d5fa748d02f566c1f00005ca782a52b7a6b0fd9dfa87: [Vertex Pharmaceuticals Incorporated director board source](https://www.sec.gov/Archives/edgar/data/0000875320/000087532025000160/vrtx-20250403.htm).
- alpha:projection-evidence:document:65aa0f473458ddc2d4211d222c40e747b4e05982619bf8cfdbf0acff95ada785: [Vertex Pharmaceuticals Incorporated director board source](https://www.sec.gov/Archives/edgar/data/0000875320/000087532025000160/vrtx-20250403.htm).
- alpha:projection-evidence:document:643565076b28be530e27bc7c6bb3b8e5c4f9d2ef18b6ed3c3477341241fc6f2d: VRTX executive roster source.
- alpha:projection-evidence:document:10073b8c8eebe93a66db157b64687d2d3997bc19eb9044ee3696d363709c8ca8: VRTX executive roster source.
- alpha:projection-evidence:document:bcba2bd490d216b470f7f5bfee08ab970104433bf97d57f0ffbc8c0646e2f879: VRTX executive roster source.
- alpha:projection-evidence:document:ecb260e2fc826c6ce0d9dc519493846b3dad9f6e6755e4e91fe7588cfad341c0: VRTX executive roster source.
- alpha:projection-evidence:document:d6d906836dc60a9cb04c04a972bfe36d39683fb549b84171d05c66770d06294e: VRTX executive roster source.
- alpha:projection-evidence:document:11c9716331af59ab69a0aebe420f77e14312aef120cdd656894afe2d18781f2b: VRTX executive roster source.
- alpha:projection-evidence:document:928c35a8eb10908bfafa795855984082d0cf83fa1beaab5098328b05eb4f4dbe: VRTX executive roster source.
- alpha:projection-evidence:document:a12b804ccfa191b0a98a7bf01680ad0b850214b84d0467db3d7f4efedc2d6e5b: VRTX executive roster source.
- alpha:projection-evidence:document:15a914491ac61cea12830ac4dae1f930b6ac324a037cb07cbd6c3f1bcb573247: VRTX executive roster source.
- alpha:projection-evidence:document:bd8e625c43229cd60017e6c676a3355f568a031ad70b6019bbdfc8ac786e4c03: VRTX executive roster source.
- alpha:projection-evidence:a272f1cf1c94c10710da2da022a424e6b3312f2261f8ff8157329e967abc5f34: [Audit](https://www.sec.gov/Archives/edgar/data/875320/000087532026000153/vrtx-20260402.htm).
- alpha:projection-evidence:827a22a1567eda11fa866650563f33918ee2975144378fa7fd6f46399da5427a: [S&P 500](https://www.slickcharts.com/sp500).
- alpha:projection-evidence:24e3e0a1948ea10a66303a2e7032cc9bbc5c4edf5c6d4eb77b262a15ea2009a5: [Nasdaq-100](https://api.nasdaq.com/api/quote/list-type/nasdaq100).
## Rights
| Field | Value |
| --- | --- |
| public_retrieval | allowed |
| agent_retrieval | allowed |
| redistribution | not_granted |
| model_training | not_granted |
| commercial_use | not_specified |
| relationship_pathfinding | not_granted |
| direct_contact | not_granted |
## Limitations
- Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
- Only explicitly published canonical company identity and current confirmed public roles are included.
- Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
- Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
- This Company Profile is an identity and evidence record, not an Alpha rating.
## Alternate representations
- [Canonical profile](https://registry.alpha.ac/companies/vertex-pharmaceuticals-inc-ma)
- [Public Markdown](https://registry.alpha.ac/companies/vertex-pharmaceuticals-inc-ma.md)
- [Public JSON](https://registry.alpha.ac/api/public/companies/vertex-pharmaceuticals-inc-ma?format=record)
- [JSON-LD](https://registry.alpha.ac/api/public/companies/vertex-pharmaceuticals-inc-ma?format=jsonld)
- MCP resource: `alpha://companies/vertex-pharmaceuticals-inc-ma` at https://mcp.alpha.ac/mcp
## Connected governance records
Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage.
## Critical-risk oversight
Snapshot as of 2026-10-16T14:35:27.921894+00:00; recorded 2026-10-16T14:35:27.921894+00:00. Every published assignment for this snapshot is listed.
Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording.
An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.Vertex Pharmaceuticals, for agents
The same record as the human view, as a structured object any agent can read and cite. Reading is open to every agent, model, and tool, with no key and no account. Signing and transparency logging are not yet published for this record.
- Alpha ID
- alpha:company:67a28a17-ff7a-4e42-a246-5086ab42eca9
- Version
- vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ceRecorded Oct 16, 2026
- Content hash
- Not yet signed
- Signature
- Not yet signed
- Transparency log
- Not yet signed
- Freshness
- ObservedChecked Oct 16, 2026. Reviewed Oct 16, 2026
- Read access
- OpenNo key for public retrieval
- Processing basis
- Public recordDoctrine
Read
OpenOne canonical URL. The Accept header or a file suffix selects the format. Every format renders the same Claims and carries the same record version.
curl -H "Accept: application/json" https://registry.alpha.ac/companies/vertex-pharmaceuticals-inc-maTrustCheck and Governance Receipts
Agent tierIllustrative. TrustChecks run in the private enterprise overlay. The example below is generated for this entity class and does not reference this record. Contract: TrustCheck and Governance Receipts v0.1.
Agents about to act ask a question, not for a document. A TrustCheck evaluates the AuthorityGrant objects behind a proposed action and returns allow, deny, require_approval, or insufficient_evidence. The source system acts, and a GovernanceReceipt records what the agent relied on.
- allow, deny
- The AuthorityGrant and policy decide. Reason codes name the rule.
- require_approval
- An entitled human records the decision. Customer policy sets the threshold, never an Eval.
- insufficient_evidence
- No authority is registered. Alpha never infers permission to act.
curl https://www.alpha.ac/v1/action-intents \
-H 'Content-Type: application/json' \
-b "$ALPHA_SESSION_COOKIE" \
-d '{
"schema_version": "2026-08-29",
"environment": "test",
"actor": { "alpha_id": "alpha:account:self", "type": "alpha_account" },
"principal": { "alpha_id": "alpha:company:example-issuer", "type": "organization" },
"organization": { "alpha_id": "alpha:company:example-issuer", "type": "organization" },
"proposed_action": { "type": "purchase_order.commit", "description": "Accept an order placed by an agent claiming company authority." },
"requested_authority": ["purchase_order.commit"]
}'
# then
curl https://www.alpha.ac/v1/trust-checks -H 'Content-Type: application/json' \
-b "$ALPHA_SESSION_COOKIE" -d '{ "action_intent_id": "<from the previous response>" }'{
"schema_version": "2026-08-29",
"trust_check_id": "alpha:trust-check:illustrative-0001",
"decision": "insufficient_evidence",
"explanation": "No AuthorityGrant names this agent and organization.",
"reason_codes": [
"authority_grant_missing"
],
"evaluated_authority": {
"authority_grants": []
},
"policy_version": "trustcheck.registry-claim.test.v0.1",
"integrity_state": "recorded",
"limitations": [
"Illustrative example. No TrustCheck was run for this record."
]
}{
"schema_version": "2026-08-29",
"receipt_id": "alpha:receipt:illustrative-0001",
"environment": "test",
"actor": {
"alpha_id": "alpha:account:self",
"type": "alpha_account"
},
"agent": {
"provider": {
"alpha_id": "alpha:company:example-agent-provider",
"type": "provider"
},
"product": {
"alpha_id": "alpha:agent-product:example-procurement-agent",
"type": "agent_product"
},
"deployment": {
"alpha_id": "alpha:agent-deployment:example-deployment",
"type": "agent_deployment"
},
"use_case": {
"alpha_id": "alpha:agent-use-case:example-purchase-order",
"type": "agent_use_case"
},
"workflow": "Illustrative purchase order commitment"
},
"principal": {
"alpha_id": "alpha:company:example-issuer",
"type": "organization"
},
"sponsor": {
"alpha_id": "alpha:company:example-issuer",
"type": "organization"
},
"action_intent_id": "alpha:action-intent:illustrative-0001",
"trust_check_id": "alpha:trust-check:illustrative-0001",
"authority_grant_references": [],
"action_intent": {
"type": "purchase_order.commit"
},
"affected_alpha_ids": [
"alpha:company:example-issuer"
],
"trust_check_decision": "insufficient_evidence",
"policy_version": "trustcheck.registry-claim.test.v0.1",
"rule_references": [
{
"reason_code": "authority_grant_missing",
"rule_id": "trustcheck.authority_grant_missing",
"policy_ref": "trustcheck.registry-claim.test.v0.1",
"control_ref": null,
"grant_policy_references": []
}
],
"integrity": "Illustrative. Not issued, not signed."
}Connect
Open readEvery surface reads the same published record. No surface holds its own copy of the facts.
// claude_desktop_config.json, Cursor, or any MCP client
{
"mcpServers": {
"alpha": { "url": "https://mcp.alpha.ac/mcp" }
}
}
// This record as an MCP resource
alpha://companies/vertex-pharmaceuticals-inc-maalpha://companies/vertex-pharmaceuticals-inc-maThis record as an MCP resourcehttps://registry.alpha.ac/api/public/companies/vertex-pharmaceuticals-inc-ma?format=recordThe same record over HTTP
Subscribe to changes
Agent tier, previewNo public subscription endpoint is published yet. Event delivery is part of Agent tier access, in preview. Access and availability.
DIRECTOR_APPOINTEDDerived governance event published on this record (alpha-governance-event-derivation-v2)COMMITTEE_CREATEDDerived governance event published on this record (alpha-governance-event-derivation-v2)COMMITTEE_MEMBER_ADDEDDerived governance event published on this record (alpha-governance-event-derivation-v2)BOARD_CHAIR_CHANGEDDerived governance event published on this record (alpha-governance-event-derivation-v2)LEAD_DIRECTOR_CHANGEDDerived governance event published on this record (alpha-governance-event-derivation-v2)
{
"specversion": "1.0",
"type": "ac.alpha.registry.DIRECTOR_APPOINTED",
"source": "https://registry.alpha.ac/companies/vertex-pharmaceuticals-inc-ma",
"subject": "alpha:company:67a28a17-ff7a-4e42-a246-5086ab42eca9",
"data": {
"record_version": "public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce",
"note": "Subscription delivery is Agent tier, preview. Not yet available publicly."
}
}Versions and changes
OpenRecords are versioned. Derived governance events on this record are listed below with the version that publishes them. Effective is the world time the derivation states; Recorded is when Alpha detected the event. Content hashes and log entries appear once records are signed.
| Version | Effective | Recorded | Content hash | Log entry | What changed |
|---|---|---|---|---|---|
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2024 | Oct 16, 2026 | Not yet signed | Not yet signed | Jennifer Schneider seat on Vertex Pharmaceuticals, effective 2024-01-01. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2024 | Oct 16, 2026 | Not yet signed | Not yet signed | MDCC; Compensation committee of Vertex Pharmaceuticals, effective 2024-01-01. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2024 | Oct 16, 2026 | Not yet signed | Not yet signed | Jennifer Schneider member of MDCC; Compensation, effective 2024-01-01. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2023 | Oct 16, 2026 | Not yet signed | Not yet signed | Michel Lagarde seat on Vertex Pharmaceuticals, effective 2023-01-01. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2023 | Oct 16, 2026 | Not yet signed | Not yet signed | Nancy Thornberry seat on Vertex Pharmaceuticals, effective 2023-01-01. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2022 | Oct 16, 2026 | Not yet signed | Not yet signed | Suketu Upadhyay seat on Vertex Pharmaceuticals, effective 2022-01-01. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2022 | Oct 16, 2026 | Not yet signed | Not yet signed | Suketu Upadhyay member of Audit; MDCC; Compensation, effective 2022-01-01. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2020 | Oct 16, 2026 | Not yet signed | Not yet signed | Diana McKenzie seat on Vertex Pharmaceuticals, effective 2020-01-01. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2020 | Oct 16, 2026 | Not yet signed | Not yet signed | Reshma Kewalramani seat on Vertex Pharmaceuticals, effective 2020-01-01. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2020 | Oct 16, 2026 | Not yet signed | Not yet signed | Audit; MDCC; Compensation committee of Vertex Pharmaceuticals, effective 2020-01-01. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2020 | Oct 16, 2026 | Not yet signed | Not yet signed | Diana McKenzie member of Audit; MDCC; Compensation, effective 2020-01-01. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2019 | Oct 16, 2026 | Not yet signed | Not yet signed | Lloyd Carney seat on Vertex Pharmaceuticals, effective 2019-01-01. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2019 | Oct 16, 2026 | Not yet signed | Not yet signed | Audit; CGNC; Nominating and Governance committee of Vertex Pharmaceuticals, effective 2019-01-01. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2019 | Oct 16, 2026 | Not yet signed | Not yet signed | Lloyd Carney member of Audit; CGNC; Nominating and Governance, effective 2019-01-01. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2017 | Oct 16, 2026 | Not yet signed | Not yet signed | Alan Garber seat on Vertex Pharmaceuticals, effective 2017-01-01. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2017 | Oct 16, 2026 | Not yet signed | Not yet signed | CGNC; Nominating and Governance committee of Vertex Pharmaceuticals, effective 2017-01-01. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2017 | Oct 16, 2026 | Not yet signed | Not yet signed | Alan Garber member of CGNC; Nominating and Governance, effective 2017-01-01. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2015 | Oct 16, 2026 | Not yet signed | Not yet signed | Sangeeta Bhatia seat on Vertex Pharmaceuticals, effective 2015-01-01. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2015 | Oct 16, 2026 | Not yet signed | Not yet signed | Sangeeta Bhatia member of CGNC; Nominating and Governance, effective 2015-01-01. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2009 | Oct 16, 2026 | Not yet signed | Not yet signed | Jeffrey M. Leiden seat on Vertex Pharmaceuticals, effective 2009-01-01. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2009 | Oct 16, 2026 | Not yet signed | Not yet signed | Jeffrey M. Leiden chairs board Vertex Pharmaceuticals, effective 2009-01-01. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 1998 | Oct 16, 2026 | Not yet signed | Not yet signed | Bruce Sachs seat on Vertex Pharmaceuticals, effective 1998-01-01. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 1998 | Oct 16, 2026 | Not yet signed | Not yet signed | Bruce Sachs lead independent director of Vertex Pharmaceuticals, effective 1998-01-01. |
Access, rights, and the public-role doctrine
Facts are open. Rights travel with every Claim and every Evidence record, so an agent sees the same terms whichever format it reads.
| Capability | Access | Agents |
|---|---|---|
| Alpha Disclosure sample | public | human process |
| Alpha public website | public | retrievable now |
| Alpha Standard, methodology, and research | public | retrievable now |
| Alpha Profiles (public executive and company records) | public | retrievable now |
| Public HTTP endpoints described by OpenAPI 3.1 | public | retrievable now |
| Alpha MCP public discovery and read-only capabilities | public | retrievable now |
| Alpha AI Readiness Eval | public | human process |
| Alpha Platform | approved access | requires approved access |
| Alpha API (authenticated operations) | approved access | requires approved access |
| Alpha MCP premium capabilities | approved access | requires approved access |
| Alpha Evals and verified assessments | custom | human process |
| Alpha Council membership | custom | human process |
| Alpha Institute education, workshops, and coaching | custom | human process |
| Governance diagnostics and institutional advisory | custom | human process |
Record limitations. Every representation states these in the same words; nothing is inferred as zero.
- Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
- Only explicitly published canonical company identity and current confirmed public roles are included.
- Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
- Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
- This Company Profile is an identity and evidence record, not an Alpha rating.
"rights": {
"public_retrieval": "allowed",
"agent_retrieval": "allowed",
"redistribution": "not_granted",
"model_training": "not_granted",
"commercial_use": "not_specified",
"relationship_pathfinding": "not_granted",
"direct_contact": "not_granted"
}
"evidence_rights": {
"evidence_records": 26,
"redistribution_allowed": 0,
"restricted_or_unknown": 26,
"classified_unknown": 26
}"data_subject": {
"basis": "public_record",
"entity": "alpha:company:67a28a17-ff7a-4e42-a246-5086ab42eca9",
"identity_ownership": "unclaimed",
"rights": {
"public_retrieval": "allowed",
"agent_retrieval": "allowed",
"redistribution": "not_granted",
"model_training": "not_granted",
"commercial_use": "not_specified",
"relationship_pathfinding": "not_granted",
"direct_contact": "not_granted"
},
"requests": "https://www.alpha.ac/contact"
}How agents find this
OpenThe page head and every response carry rel="alternate" links and the Registry's Link header. The list below is generated from the same list the server emits.
/.well-known/ai-catalog.jsonAlpha Agentic Resource Discovery manifest/.well-known/api-catalogapi-catalog/.well-known/webmcp.jsonAlpha WebMCP tool discovery/openapi.jsonAlpha Governance Public Intelligence API (OpenAPI 3.1)/apiAlpha Intelligence API/developersAlpha Governance Developer Platform/docs/trustcheck-receipts-v01.mdTrustCheck and Governance Receipts v0.1 test preview/docs/apiAlpha service documentation/llms.txtAlpha service docs for AI agents/agents.mdAlpha agent instructions (when to use Alpha)/api-versioning.mdAlpha public API versioning and deprecation policy/.well-known/agent-skills/index.jsonAgent Skills Index/products/accessAlpha Access and Availability/api/public/product-accessAlpha Product Access and Availability JSON/api/public/auth-capabilitiesAlpha Authentication Capabilities JSON/peopleAlpha Executive Profiles/companiesAlpha Company Profiles/people/readinessAlpha Profile Coverage and Agent Readiness/api/public/profile-readinessAlpha Public Profile Readiness JSON/api/public/profiles/steven-wolfe-pereiraAlpha Public Profile JSON Example/.well-known/agent-card.jsonA2A Agent Card/.well-known/mcp/server-card.jsonMCP Server Card/.well-known/openid-configurationOpenID Configuration/.well-known/oauth-protected-resourceOAuth Protected Resource/.well-known/oauth-authorization-serverOAuth Authorization Server (agent_auth)/.well-known/agent-registrationAgent Registration/.well-known/http-message-signatures-directoryhttp-message-signatures-directory/.well-known/jwks-rotationJWKS Rotation Policy/auth.mdAgent Authentication/llms.txtSite overview for AI agents/sitemap.xmlsitemap/api/public/agent-readinessAgent Readiness Status/api/public/company-report/osw-market-dataOSW Market Data Verification
Record map and assertion states
| Section | Anchor | Resource | State | Claims |
|---|---|---|---|---|
| Identity | #c-subject | /identity | Published | 0 |
| Corporate structure | - | /corporate_structure | Not reviewed | - |
| Board | #c-board | /board | Published | 11 |
| Committees | #c-committees | /committees | Published | 21 |
| Leadership | #c-leadership | /leadership | Published | 10 |
| Ownership | #c-control | /ownership | Not reviewed | 0 |
| Financials | #c-financials | /financials | Not reviewed | 3 |
| Capital structure | - | /capital_structure | Published | - |
| Compensation | #c-comp | /compensation | Not reviewed | 0 |
| Governance | #c-governance | /governance | Not reviewed | 0 |
| Shareholder governance | - | /shareholder_governance | Not reviewed | - |
| Audit | - | /audit | Not reviewed | - |
| Legal | #c-legal | /legal | Not reviewed | 0 |
| Risk | #c-risk | /risk | Not reviewed | 0 |
| Cyber | - | /cyber | Not reviewed | - |
| AI governance | #c-ai | /ai_governance | Not reviewed | 0 |
| Agent governance | #c-authority | /agent_governance | Restricted | 0 |
| Markets external | - | /markets_external | Published | - |
| Events | #c-history | /events | Published | 23 |
| Relationships | #c-links | /relationships | Published | 21 |
| Assessments | #c-monitor | /assessments | Published | 0 |
| Evidence | #c-evidence | /evidence | Published | 26 |
- corroboratedTwo or more independent sources agree
- source_reportedOne cited source states it
- alpha_inferenceAlpha's conclusion, with reasoning
- not_disclosedSearched, nothing found. Never rendered as false
- not_reviewedNot yet searched
- not_registeredNo authority registered with Alpha



